Greatview Aseptic Packaging (GAPACK) Raises Connected-Party Procurement Cap to RMB90 Million Following Inclusion of Shandong NewJF

Bulletin Express11-06

Greatview Aseptic Packaging Company Limited (GAPACK) and three wholly-owned subsidiaries—Greatview Shandong, Greatview Inner Mongolia and Greatview Beijing—signed a Supplemental Procurement Framework Agreement on 6 November 2026 with Shandong Xinjufeng Taidong and parent company Shandong NewJF. The supplemental pact formally adds Greatview and Shandong NewJF as seller and purchaser, respectively, under the existing February 2026 procurement framework.

The enlarged arrangement lifts the annual cap on aggregate transactions for packaging-material sales to Shandong NewJF and its subsidiary from RMB50 million to RMB90 million for each of the financial years ending 31 December 2026 and 31 December 2027. The revision reflects (1) higher forecast demand from Shandong NewJF and Shandong Xinjufeng Taidong, (2) the Group’s available production capacity, (3) prevailing and expected market pricing for aseptic packaging materials, and (4) the prior-year transaction volume, which totaled approximately RMB0.14 million in 2025.

Pricing will continue to be negotiated on normal commercial terms with reference to market conditions, order size, comparable third-party quotations and cost considerations. All other terms of the original framework agreement remain unchanged.

Because Shandong NewJF owns 97.76% of Greatview’s shares and its subsidiary Shandong Xinjufeng Taidong is wholly owned, both counterparties are classified as connected persons under Hong Kong Listing Rule 14A. The revised annual cap exceeds the 0.1% but remains below the 5% percentage ratio threshold, subjecting the transactions to reporting, announcement and annual review requirements while exempting them from circular and independent shareholder approval.

Only Executive Director Mr. Yuan Xunjun—who also serves as chairman of Shandong NewJF and executive director of Shandong Xinjufeng Taidong—abstained from the Board vote on the supplemental agreement; all other directors approved the transaction.

Greatview emphasised that expanding the framework to multiple group entities will provide operational flexibility and support revenue growth in line with its strategic objectives to supply integrated aseptic packaging solutions. Trading in GAPACK shares remains suspended since 19 February 2025 pending further notice.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment